piracetam


Also found in: Medical, Wikipedia.

piracetam

(paɪˈræsəˌtæm)
n
(Pharmacology) pharmacol a drug used to improve cognitive powers and memory, used to treat stroke victims and sufferers of dementia, Alzheimer's disease, etc
References in periodicals archive ?
NEPG is proud of being the first Vitamin C producer in China, as well as the inventor of the two steps fermentation technology of VC production; Piracetam products capacity is the biggest one in the world; NEPG is the leading Fosfomycin producer in China.
They were treated in the following way; G-I = 10 ml/kg/p.o, normal saline, G-II = 10 ml/kg/p.o, 5% CMC, G-III and IV = 200 mg/kg/p.o, piracetam, G-V to VII = aqP.a in doses 200, 400 and 800 mg/kg/p.o, respectively and G-VIII to G-X = nhP.a doses 200, 400 and 800 mg/kg/p.o, respectively, for seven days consecutively.
Group I treated as vehicle control (normal saline), Group II was treated with standard - (Piracetam 400 mg/kg/i.p.) and Groups III and IV were administered two different doses of EASL 50, 250 mg/kg/per orally, Group V is treated with scopolamine (0.4 mg/kg p.o)., respectively, which were administered up to 7 days.
Valproic acid (VPA) is typically the first pharmacological treatment for myoclonic seizures; however, its mitochondrial toxicity provides limitations for use in the treatment of mitochondrial disorders.[4],[5] Other commonly used agents include levetiracetam (LEV), clonazepam (CZP), zonisamide (ZNS), topiramate (TPM) and a high dose of piracetam.[2],[6] Recent evidence has supported the use of LEV as the first line of treatment for myoclonic seizures; however, the treatment effects have been unsatisfactory and inconsistent.[7],[8],[9] Therefore, additional clinical trials must be conducted to find more suitable treatments for myoclonic seizures in MERRF.
She used betahistine, corticosteroids (oral and intratympanically), piracetam, trimetazidine, ginkgo biloba, and cinnarizine.
Double-blind, placebo-controlled trial on the effect of piracetam on breath-holding spells.
[23,24] Recently, evidence for safe and effective use of piracetam, especially in hyperactive children to control Breath holding spells has emerged, but it still lacks FDA approval.
LEV is a pyrrolidone derivative that has been developed from piracetam. It is presumed to act on presynaptic neurotransmitter release by binding to synaptic vesicle protein 2A (SV2A), a glycoprotein that is part of the membrane of presynaptic neurotransmitter-containing vesicles in neurons and neuroendocrine cells.
Rosa et al., "Piracetam prevents scopolamine-induced memory impairment and decrease of NTPDase, 5'-nucleotidase and adenosine deaminase activities," Neurochemical Research, vol.
The effect of piracetam on Danio rerio with ethanol-induced memory impairment.
The first nootropic drug put on the market was piracetam in 1971.